Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor

GM McGeehan, JD Becherer, RC Bast Jr, CM Boyer… - Nature, 1994 - nature.com
TUMOUR necrosis factor-αa (TNF-α) is a potent pro-inflammatory agent produced primarily
by activated monocytes and macrophages 1 . TNF-α is synthesized as a precursor protein of …

Tumor necrosis factor α as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor α …

S Wu, CM Boyer, RS Whitaker, A Berchuck, JR Wiener… - Cancer research, 1993 - AACR
Ovarian tumor cells produce macrophage colony stimulating factor, a potent chemoattractant
for monocytes. Monocytes and macrophages produce tumor necrosis factor α (TNF-α) and …

Coalbed-and shale-gas reservoirs

CD Jenkins, CM Boyer - Journal of Petroleum Technology, 2008 - onepetro.org
Boyer earned a BS degree in geological sciences from The Pennsylvania State University
and completed graduate studies in mining and petroleum engineering at the University of …

Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially …

KR Jerome, DL Barnd, KM Bendt, CM Boyer… - Cancer research, 1991 - AACR
A population of tumor-reactive cytotoxic T-cells can be propagated from tumor-draining lymph
nodes of patients with breast adenocarcinoma. These T-cells specifically recognize breast …

Cell growth regulation in epithelial ovarian cancer

RC Bast Jr, CM Boyer, I Jacobs, FJ Xu, S Wu… - Cancer, 1993 - Wiley Online Library
… Immunotoxins against certain epitopes on the extracellular domain of p185 can eliminate
99.99% of clonogenic tumor cells that overexpress p185 (Boyer CM. Unpublished data, 1992).…

Serum levels of HER‐2 neu (C‐erbB‐2) correlate with overexpression of p185neu in human ovarian cancer

…, DR Hollis, RS Whitaker, A Berchuck, CM Boyer… - Cancer, 1993 - Wiley Online Library
Background. The HER‐2 neu (c‐erbB‐2) oncogene product p185 neu is expressed by most
ovarian cancers and overexpressed in approximately 30%. Methods. Sera from patients with …

Requirements for the Internalization of a Murine Monoclonal Antibody Directed against the HER-2/neu Gene Product c-erbB-2

LA Maier, FJ Xu, S Hester, CM Boyer, S McKenzie… - Cancer research, 1991 - AACR
A murine monoclonal antibody, TA1, is directed against an epitope on the extracellular domain
of the HER-2/neu (c-erbB-2) gene product. Requirements for TA1-induced internalization …

Green recovery: how are environmental stocks doing?

C Boulatoff, CM Boyer - The Journal of Wealth Management, 2009 - search.proquest.com
BOYER is an assistant professor in finance at College of Management, Long Island University
in Brookville, NY. carol.boyer@liu… CATHERINE BOULATOFF AND CAROL MARIE BOYER

Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-α

…, JM Watson, DS Silberstein, CM Boyer… - American journal of …, 1992 - Elsevier
Objective: We investigated whether monocyte-derived factors could stimulate the growth of
ovarian cancer cells. Study Design: Human peripheral blood monocytes or human monocyte-…

Antibody‐induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c‐erbb‐2 (her‐2/neu) …

…, Y Yu, KA Desombre, CM Boyer… - … journal of cancer, 1993 - Wiley Online Library
Over‐expression of the c‐erbB‐2 (HER‐2/neu) gene product p185 occurs in 30% of breast
and ovarian cancers. The p185 protein might serve as a target for serotherapy in that …